Vol. 68, No. 1, 1976
ON THE
BIOCHEMICAL
THE EFFECT FIBRINOLYTIC
W.E. Division
Received
Laug’,
AND BIOPHYSICAL
OF CYCLIC ACTIVITY
P.A.
AMP AND PROSTAGLANDI NS OF MOUSE NEUROBLASTOMA
Jones*,
C.A.
of Hematology-Oncology, 4650 Sunset Boulevard,
October
17,
RESEARCH COMMUNICATIONS
Nye
and
W.F.
CELLS
Benedict3
Childrens Hospital Los Angeles, Ca
of 90027
Los
Angeles
1975
SUMMARY. The Cl300 mouse neuroblastoma cell line was found to produce plasminogen activator which is secreted into the growth medium. The intraand extracellular activities of this enzyme were markedly increased (up to 14 fold) by treatment with cyclic AMP agents. Prostaglandins El and E2 and butyric acid were the most efficient inducers followed by propionic acid and dibutyryl cyclic AMP. Theophylline was found to be ineffective. The highest enzyme activities were found in cells exposed simultaneously to prostaglandin and dibutyryl cyclic AMP. I NTRODUCTI
ON.
Many
activator
which
appears
This
activity
is
species
including
induced
to
agents
in
cells
to
found
in
human
be
vitro
(6),
in
activity,
since
activator
can
of
the
glucocorticoids
have
induced can
in
vitro
with
the derived
neuroblastoma
(5).
Since
and
their
enzymatic
change to
mouse
study
Cl300 that
the
these
that
in
(7).
Also,
inhibit
the
Address: Address:
3To
the
reprint
whom
FCS,
Wigler
114 Copyrighf A It rights
0 I976 by Academic Press, of reprodzcction in any form
Inc. reserved.
PBS,
cells
can
these
agents
on
We were
of
et.
al.
CH3000,
AMP the
fibrinolytic plasminogen (8)
have of
Berne,
shown
tumor
passage 62 cells were IO% (v/v) were seeded The Cal.
63, Tygerberg
be
particularly
influence
activity
Box
and
cyclic
secretion
fibrinolytic
fetal calf serum; Adenosine 3’:5’-cyclic El and E2.
tissues
by
of
might
(l-4).
functions
cells.
University Childrens Hospital, Dept. Medical Biochemistry, South Africa. requests should be addressed.
Abbreviat’ons used: dbcAMP, N 6 , 02-Dibutyryl and PGE2, prostaglandins
phenotype several
METHODS : The uncloned Cl300 line was kindly provided in The Finkels tein, Harbor General Hospital, Torrance, Cal. Minimum Essential Medium (GIBCO) supplemented with Eagle’s and streptomycin (100 units/ml). Cells (5x105) penici 1 lin 100 mm tissue culture dishes obtained from Falcon, Oxnard, 1 Present *Present
a plasminogen
neuroblastoma
effects
agents
found
strongly
from
neuroblastoma
recently vivo
produce transformed
cells
possibility we
be
associated
we decided
activity
grown
transformed
“differentiate”
fibrinolytic interested
malignant
El
cells. by J.Z. grown in FCS and into growth
Switzerland. 7505,
phosphate buffered monophosphoric acid;
that
saline; PGE,
Vol.
68,
No.
BIOCHEMICAL
1, 1976
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
medium
was changed to test medium 24 hr later. Test medium always contained (v/v) FCS since FCS does not interfere with the fibrinolysis assay but, on the contrary, appears to stimulate protease secretion (7). Control cultures were fed with the growth medium supplemented with calcium and magnesium free PBS (GIBCO) or 96% ethanol respectively at the same concentration as used as solvents for the cyclic AMP-agents. dbcAMP (Sigma), theophylline (Calbiochem), butyric acid and propionic acid were dissolved in PBS and added to the growth medium. PGEL and PGE2 (personal gifts from Dr. J. Pike, Upjohn Co.,Kalamazoo, Mich.), were dissolved in 96% ethanol. Growth medium supplemented with the solvents and compounds respectively was changed after 48 hr incubation at 37’. Extracellular fibrinolytic activity was determined in aliquots of the superAt the same time photomicrographs were made of dishes natant taken after 96 hr. seeded with lo5 cells and the percentage of “differentiated” ccl Is determined on a minimum sample of 100 cells (9). After 96 hr of exposure to the compounds the medium was removed and the cell cultures washed once with PBS. The cells were then either trypsinized and counted in a Coulter counter or scraped off the dish with a rubber policeman when they were to be lysed for fibrinolysis assays. Gel lular protein levels were determined by scraping the cells directly into cold 5% perchloric acid and determining the protein by the method of Lowry et. al. (10). Intracellular plasminogen activator was determined in cell lysates prepared with 0.5% Triton X-100 as previously described (7). Lysates( lo-20 ul) were incubated with 2.5 ml of freshly prepared 0. IM Tris-HCI pH 8.1 containing 1% acid treated pooled human serum as plasminogen source onp25l]fibrin plates. The appearance of radioactivity in the supernatant was used as a measure of fibrinolytic activity with one unit of activity defined as previously (7). The plasminogen activator secreted by the cells was assayed in IO-20 ul aliquots of growth medium incubated on p251]fibrin plates exactly as outlined above.
10%
RESULTS.
Table
growth
of
Cl300
extensions
the
cells.
was
not
particularly
All
simply
“neurite” these
two
that
the
when
compared
exposed The lysates fibrinolytic added
level
compounds
caused
to
effect of
activity
ccl
plasminogen
and
these is
(i.e.
growth
cultures
shown the
and on
the
as
a
lysates acid
treated
not
both
and
human
again due
115
to
dose medium
in was result
dbcAMP
and
1 also
shows
in
not
cells
inhibition Triton
X-100
1.
totally
of
increased
growth
Figure
in-
level
greatest
of
a
severly
agents
activity
serum,
not
and
ex-
induce
highest
these
with
the
not
Table
was
of growth
did
inhibition.
fibrinolytic function
of
PGE,
with
cells with
did
which
simply
of
cells
acid)
to
increase
was
of
The
treated
This
number
extensions.
growth
1s.
the
and
effects
dbcAMP
exposed
cells
morphology
number
(butyric
of
the
inhibitory
Also,
of
PGEl agents
of
the
considerable
untreated
cells
The
compound
in
on
exposure.
percentage
seen
agents increased
“neurites.”
levels
dbcAMP
these
compounds hr
to
protein
of
Cl300
96
a higher was
both
the
inhibitory of
outgrowth
cellular
to
most
caused
growth,
of
of
related
the
high
t
effect
after
since
chemicals,
on
shows
(“neurites”)
tensions
hibi
I
The dependent
shown).
Ex-
Vol.
68, No.
1, 1976
BIOCHEMICAL
AND
BIOPHYSICAL
Table Effects
of
Cyclic
AMP Agents
on
Treatment
Neuroblastoma
Control PGE,
(~xIO-~M)
dbcAMP
(IO-‘M)
PGEl + dbcAMP (3~10-5M)(lO-~M) Butyric Propionic Theophylline
Cell
%
Acid Acid
( 10m3M) (10m3M) (10v3M)
96
Morphology
and
Protein/ Cell. % Control
Cells
hr
COMMUNICATIONS
I
“Differentiated” 24
RESEARCH
Cell Dish.
Growth
Number/ % Control
hr
21
4
27
23
137
70
44
29
121
89
72
63
175
29
22
21
110
25
16
13
118
101
27
17
106
87
Cl300 cells were treated with the indicated doses of compounds 24 hr after seeding and the percentage of cells with long extensions (“differentiated” cells) counted at 24 and 96 hr after exposure, The cell number and protein content per cell were also determined 96 hr after exposure and compared to control cultures. t 96 hr were about 13 x lo6 cells/dish Control values with a protein content of 97 ug/lO % cells.
I
I
400 -I g 300!? 8 g 200 loo-
i
/ffj IO-7
10-s
IO-5
IO-4
IO-3
IM1 Effect of cyclic AMP agents on the intracellular fibrinolytic Figure I. activity of Cl300 cells. Cultures of Cl300 cells were exposed to the agents 24 hr after seeding and the cells harvested after 96 hr treatment. Cell centrifuged and plasminogen activator depellets were lysed in Triton X-100 termined in the supernatant using t251]fibrin plates incubated with 1% acidThe protein content of the lysates was determined and the treated human serum. specific activity of the enzyme compared to that of untreated controls. The agents used were ; PGEl ( A ); PGE2 ( A ); butyric acid ( ); propionic acid ( l ); dbcAMP ( n ); theophylline ( 0 ). Control values ranged from units/mg protein and the points represent the mean values obtained 5.9 - 14.7 from duplicate dishes in 2-4 separate experiments.
0
116
BIOCHEMICAL
Vol. 68, No. 1, 1976
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Fiqure 2. Effect of cyclic AMP agents on the secretion of plasminogen activator by Cl300 cells. Cultures of Cl300 cells were treated as in Figure 1 and plasmino en activator determined in the culture fluids after 96 hr treat9 ment using 1*5l]fibrin plates incubated with 1% acid-treated human serum. The cell number present after treatment was also determined and the amount of enzyme secreted was normalized for cell number and then compared to untreated controls. The agents used were; PGEl ( A ); butyric acid ( 0 ); propionic acid ( l ); dbcAMP ( m ); theophylline ( Q ). Control values ranged from g-29 units/l06 cells and the points represent the mean values obtained from duplicate cultures in 2-3 separate experiments.
periments with
with
lysates
increasing
protein
Therefore
although
they
not
were
aliquots PGEl
and
inhibitors
measured
pionic
its
were
this
enzyme.
tory
properties
of
can
be due
creases the
enzyme
over
the x
minogen
Since
also
capable
there these to
10m5M)
and
activator
range
acids
Cl300
used.
dbcAMP (not
and
ug
of of
(10V3M)
all
1)
it
and found
that a 650%
shown).
117
30
assays
were
conducted
20-50
ug/assay).
present
specific
seems
the
in in
the
unlikely
Both of
that
plas-
and pro-
the
activity
growth
that
shows
lysates,
on
Butyric
increases
linear
ug/ml).
in
activity
used.
1 also that
was
be
large
Figure
caused
(i.e.
differences
(Table
assay
ug/assay
concentrations inducing
the
might
the
substantial
was
that
(range
increased
lysates It
75
protein
cytotoxicity. in
range
75
were
to
fibrinolysis
PGE2 the
showed
up
assay
than
over
activity dose
this
relative
activator
cells
of
by less
close
acids
untreated
concentration
containing
mi nogen
(3
of
inhibi-
these dbcAMP
theophylline
was
ineffective
a combined
treatment
with
increase
in
intracellular
of
inraised
PGEl plas-
Vol. 68, No. 1, 1976
Figure
2 shows
plasminogen those
the
observed
into
for
than
PGE,
(3 x 10m5M)
extracel
lular
the
propionic
DISCUSSION.
and
The
dbcAMP
agents
which
enzymes
(4
is
unlikely
(II), amongst to
be
40
fold)
that
the
were
in
the
range
ante
of
the
morphological
to The
ferase Also, of
activity
butyric
shape
(13)
and
acid
differentiation
increases butyric of
the
the
active treated
the acid role
in
cultured
endogenous
of
CAMP
in
cells.
in
the
treated
effec-
dose
of of
2 could
also
and
that
of
activity
these of
agents.
It
inhibitors
of
concentrations we
confirmed
indicative
of
increased
as
these
fibrinolytic
with
Although be
such
sialytrans-
increase
protein
to
including
enzymes
levels at
fatty of
a lesser
of
more
which the
appear-
differentiation,
fibrinolytic
activity
are
stage.
HeLa
acids
interest. cells
It
and
induces
alkaline extent
level
CAMP Thus increase
cells
introduces
many
we
at
of
cannot fibrinolytic
dbcAMP.
118
has
been
acid cells
Cl300
induce
large
that
in
sialyltrans-
(16). problems this
are
(15).
stage activity
increases
reported
increases
propionic
of
can
phosphatase
erythroleukemic
CAMP
derivatives
intermediate with
to
cells
in
decreasing
membrane-bound
and
to
level
cells
several
range
considered
also
of
the
of
irreversible
(6)
assay.
short-chain is
of
conducted the
similar
Figure
neuroblastoma
show
and
this
that
activity
were
thus was
in
in
many
clearly
to
“differentiation”
observation
alters
due
of
at
induce
a wide
Cl300
changes
establish
fibrinolytic
is
linearity
between
difficult
butyrate
of
is
in
assays
increase shown
activities
results
increase
since
correlations
our
secretion
A combined
1400%
Cl300
There
the
agents.
used
the
dbcAMP
acetyltransferase
increased the
have
and
a
are
that
increases
the
choline
and
secretion.
COMMUNICATIONS
influence results
enzyme
cultured
others.
markedly
fibrinolysis,
in
in
(6)
acetylcholinesterase (12)
of
we
The except
caused
RESEARCH
to
enzyme
The
addition
agents
medium.
shown).
alterations
ferases
growth
( 10m3M)
(not
BIOPHYSICAL
these
inducing
functions
morphological
also
in
after
“differentiated”
can
the
acid
24 hr
of
intracellular
enzyme
detected
AND
abilities
activator
tive
be
BIOCHEMICAL
activity
(14).
potent
inducers
Butyric
acid
Clearly, in be
sodium
the the
of
interpretation
certain in
use
also
Cl300
of cells
the
BIOCHEMICAL
Vol. 68, No. 1, 1976
The treated
large with
secretion ently ing
increases these
of
cell
agents factor
investigating whether
No.
recipient
of
types
This NOl-CP-55641 a Career
is
activity
of
interest
be
induced
biochemical
cell
ACKNOWLEDGEMENTS.
fibrinolytic
can
the
other
Contract
in
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
in in
nature
respond
to
investigation from
Development
the
was National Award
view vivo of
these
from
seen of
when
our
(7). the
Cl300
cells
observation We are
induction
that
therefore as
are
well
the curr-
as
determin-
agents.
supported
by
Cancer
Institute.
the
N.I
Public
Health W.B.
Service is
the
.H.
REFERENCES
1. 2. 3. 4.
2:
2 9. 10. 11. 12. 13. 14. 15. 16.
Unkeless, J.C., Tobia, A., Ossowski, L., Quigley, J.P., Rifkin, D.B., and Reich, E., (1973) J. Exptl. Med., m 85-111. Ossowski, L., Unkeless, J.C., Tobia, A., Quigley, J.P., Rifkin, D.B., and Reich, E., (1973) J. Exptl. Med., u 112-126. Laug, W.E., Jones, P.A., and Benedict, W.F., (1975) J. Natl. Cancer Inst., 173-179. 5!I! Pollack, R., Risser, R., Conlon, S., and Rifkin, D., (1974) Proc. Natl. Acad. Sci. U.S., 2 4792-4796. Wachsman, J.T., and Biedler, J.L., (1974) Exptl. Cell. Res -9 -86 264-268. Prasad, K.N., and Kumar, S., (1974) Control of Proliferation in Animal Cells, pp. 581-594. Cold Spring Harbor Laboratory, New York. Jones, P.A., Laug, W.E., and Benedict, W.F., (1975) Cell 6 245-252. -Wigler, M., Ford, J.P., and Weinstein, I.B., (1975) Proteases and Biological Control, in press, Cold Spring Harbor Laboratory, New York. Schubert, D., and Jacob, F., (1970) Proc. Natl. Acad. Sci. U.S., G 247-254. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J., (1951) J. Biol. Chem. 191 265-275. Prasad, K.N., Vernadakis, A., (197.2) Exptl. Ceil. Res. a 27-32. Moskal, J.R., Gardner, D.A., and Basu, S., (1974) Bochem. Biophys. Res. Commun., & 701-708. Fishman, P.H., Simmons, J.L., Brady, R.O., and Freese, E., (1974) Biophys. Res. Commun.,jj Biochem. 292-299. Griffin, M.J., Price, G.H., and Bazzel, K.L., (1974) Arch. Biochem. Biophys., 164 619-623. Leder, A., and Leder, P., (1975) m 5 319-322. Glazer, R. I., and Schneider, F.H., (1975) J. Biol. Chem., w 2745-2749.
119